Click (NASDAQ:CLIK) Posts Quarterly Earnings Results

Click (NASDAQ:CLIK) announced its quarterly earnings results on Monday. The company reported $0.10 earnings per share for the quarter, FiscalAI reports. The company had revenue of $3.79 million for the quarter.

Click Price Performance

NASDAQ CLIK traded down $0.07 on Monday, hitting $2.17. The stock had a trading volume of 43,211,404 shares, compared to its average volume of 1,521,150. The company’s 50-day moving average is $2.75 and its two-hundred day moving average is $4.55. Click has a one year low of $1.32 and a one year high of $34.20.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (d)” rating on shares of Click in a research note on Friday, March 27th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has an average rating of “Sell”.

Click Company Profile

Click Therapeutics, Inc (NASDAQ: CLIK) is a clinical-stage digital therapeutics company developing software-based treatments for neurological, psychiatric and chronic diseases. Its platform delivers prescription digital therapies via mobile and web applications, combining evidence-based cognitive behavioral interventions, digital monitoring tools and patient engagement techniques. Click’s approach is designed to complement or extend traditional pharmacological and behavioral treatments for conditions such as major depressive disorder, insomnia and tobacco use disorder.

Founded in 2014, Click has progressed multiple programs through randomized controlled trials and regulatory review.